Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
2 other identifiers
interventional
40
1 country
1
Brief Summary
To provide a comprehensive yoga therapy (CYT) program to patients with ovarian, fallopian tube, or primary peritoneal cancer who are scheduled to receive chemotherapy and then undergo surgery. Researchers want to learn about the effects of the program on patients' quality of life and other outcomes described below.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable ovarian-cancer
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2024
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedStudy Start
First participant enrolled
June 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
November 26, 2025
November 1, 2025
2.1 years
August 5, 2024
November 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To assess the feasibility of a CYT prehabilitation program in women with ovarian cancer scheduled to receive NACT and IDS.
Through study completion; an average of 1 year
Study Arms (2)
CYT - Prehab Yoga Intervention + ERAS
EXPERIMENTALWLC - Wait List Control + ERAS
EXPERIMENTALInterventions
Two visits per week with a yoga therapist while receiving neoadjuvant chemotherapy to cover dietary counseling, yoga-based movement practices, breathwork practices, mind practices, and behavioral support for the purpose of preparing patients' mind and body for a planned surgery.
Usual care supportive services while receiving neoadjuvant chemotherapy.
Eligibility Criteria
You may qualify if:
- Women with stage III-IV epithelial ovarian, fallopian tube, primary peritonal cancer with recommendations for NACT/IDS at recruitment.
- Able to read, write, and speak English.
- years of age or older.
- Oriented to person, place, and time.
- Access to internet connection.
- Access to a tablet, laptop or computer or smart phone.
- Access and ability to do virtual sessions.
- \. Plan for surgical intervention at MD Anderson Cancer Center 9. Performance status 0-2.
You may not qualify if:
- Have completed chemotherapy.
- Any major thought disorder (e.g., schizophrenia, dementia).
- Any major communication barriers that would preclude being able to complete the intervention (e.g., visually or hearing impaired).
- Extreme mobility issues (e.g., unable to get in and out of a chair unassisted).
- Have a regular mind-body practice or an established yoga practice.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lois Ramondetta, MD
M.D. Anderson Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2024
First Posted
August 9, 2024
Study Start
June 6, 2025
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
November 26, 2025
Record last verified: 2025-11